Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × anlotinib × Clear all

NCT05817214 2024-04-19

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT02584478 2023-11-08

AL3818

Phase 3 Unknown

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05137171 2021-11-30

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT02558348 2019-06-19

AL3818

Phase 1/2 Terminated

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms